This funding opportunity advances malignant mesothelioma research by expanding a national virtual bank of biospecimens and associated demographic and clinical data. It supports the collection and sharing of tumor tissues, blood, DNA, RNA, and protein samples alongside patient data to facilitate biomarker development, early disease detection, and improved treatments. The virtual bank serves as a centralized resource for biomedical and clinical researchers focused on mesothelioma.
Eligible applicants include U.S. state, county, city, and tribal governments, public and private educational institutions, nonprofits, for-profit organizations, and small businesses. Applicants must have an established mesothelioma registry and tissue bank capable of functioning as a national virtua
